Public interests over adult vaccines in China 2022, by type of vaccines

Published by
Wenyi Zhang,
Jun 15, 2022
A survey conducted in January 2022 concluded that more than three out of four people in China were following the information regarding COVID-19 vaccines. While HPV, hepatitis B, and influenza vaccines also enjoyed strong public interest and awareness, less attention was paid to vaccines against MMR and varicella.

Public interests over different vaccines for adults in China as of January 2022, by type of vaccines

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

January 2022

Region

China

Survey time period

January 2022

Number of respondents

60,420 respondents

Method of interview

Online survey

Supplementary notes

Original survey question: Which of the following adult vaccine types do you have interests in?

29 percent of the respondents were male, while 71 percent were female.

10 percent of respondents were born before 1980, 29 percent between 1980 and 1990, 29 percent between 1990 and 1995, 22 percent between 1995 and 2000, 10 percent after 2000.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Chinese COVID-19 vaccines "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Chinese COVID-19 vaccines

Overview

6

Sinovac

6

Sinopharm and CanSino

6

Domestic adoption

5

Exports

5

Further Content: You might find this interesting as well

Topics

Chinese COVID-19 vaccinesCoronavirus COVID-19 in ChinaPharmaceutical industry in ChinaVaccine industry in ChinaCoronavirus disease (COVID-19) pandemic
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu